1 S. B. Killick, N. Bown, J. Cavenagh, I. Dokal, T. Foukaneli, A. Hill, P. Hillmen, R. Ireland, A. Kulasekararaj, G. Mufti, J. A. Snowden, S. Samarasinghe, A. Wood, J. C. Marsh, and Haematology British Society for Standards in, 'Guidelines for the Diagnosis and Management of Adult Aplastic Anaemia', Br J Haematol, 172 (2016), 187-207.
2 Torres HA, Bodey GP, Rolston KV, Kantarjian HM, Raad II, and Kontoyiannis DP, 'Infections in Patients with Aplastic Anemia: Experience at a Tertiary Care Cancer Center', Cancer, 98 (2003), 86-93.
3 Jung SM, Kim YJ, Ryoo SM, Sohn CH, Seo DW, Lim KS, and Kim WY, 'Cancer Patients with Neutropenic Septic Shock: Etiology and Antimicrobial Resistance', The Korean journal of internal medicine (2019).
4 S. Samarasinghe, P. Veys, A. Vora, and R. Wynn, 'Paediatric Amendment to Adult Bsh Guidelines for Aplastic Anaemia', Br J Haematol, 180 (2018), 201-05.
5 olivares, 'Tratamiento Exitoso De Una Fusariosis Diseminada En Un Paciente Neutropénico Febril Con Terapia Antifúngica Combinada De Voriconazol Más Anfotericina B Deoxicolato', (2018).
6 Samanta A, Chandra J, Kaur R, Anand R, Shukla S, and Mandal P, 'Clinical Profile and Microbiological Spectrum of Febrile Neutropenic Episodes in Children with Severe Aplastic Anemia', Journal of pediatric hematology/oncology (2019).
7 Garcia-Vidal C, Cardozo-Espinola C, Puerta-Alcalde P, Marco F, Tellez A, Agüero D, Romero-Santana F, Díaz-Beyá M, Giné E, Morata L, Rodríguez-Núñez O, Martinez JA, Mensa J, Esteve J, and Soriano A, 'Risk Factors for Mortality in Patients with Acute Leukemia and Bloodstream Infections in the Era of Multiresistance', PloS one, 13 (2018), e0199531.
8 Daef EA, Elsherbiny NM, Agban MN, Riad KF, and Mohammed LF, 'Bloodstream Infections in Febrile Neutropenic Pediatric Cancer Patients: Microbiological and Sepsis Biomarkers Insight', The Egyptian journal of immunology, 25 (2018), 21-34.
9 Cattaneo C, Di Blasi R, Skert C, Candoni A, Martino B, Di Renzo N, Delia M, Ballanti S, Marchesi F, Mancini V, Orciuolo E, Cesaro S, Prezioso L, Fanci R, Nadali G, Chierichini A, Facchini L, Picardi M, Malagola M, Orlando V, Trecarichi EM, Tumbarello M, Aversa F, Rossi G, and Pagano L, 'Bloodstream Infections in Haematological Cancer Patients Colonized by Multidrug-Resistant Bacteria', Annals of hematology, 97 (2018), 1717-26.
10 Trecarichi EM, and Tumbarello M, 'Antimicrobial-Resistant Gram-Negative Bacteria in Febrile Neutropenic Patients with Cancer: Current Epidemiology and Clinical Impact', Current opinion in infectious diseases, 27 (2014), 200-10.
11 Trecarichi EM, Pagano L, Candoni A, Pastore D, Cattaneo C, Fanci R, Nosari A, Caira M, Spadea A, Busca A, Vianelli N, and Tumbarello M, 'Current Epidemiology and Antimicrobial Resistance Data for Bacterial Bloodstream Infections in Patients with Hematologic Malignancies: An Italian Multicentre Prospective Survey', Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 21 (2015), 337-43.
12 Agarwal M, and Larson EL, 'Risk of Drug Resistance in Repeat Gram-Negative Infections among Patients with Multiple Hospitalizations', Journal of critical care, 43 (2018), 260-64.
13 Girmenia C, Bertaina A, Piciocchi A, Perruccio K, Algarotti A, Busca A, Cattaneo C, Raiola AM, Guidi S, Iori AP, Candoni A, Irrera G, Milone G, Marcacci G, Scimè R, Musso M, Cudillo L, Sica S, Castagna L, Corradini P, Marchesi F, Pastore D, Alessandrino EP, Annaloro C, Ciceri F, Santarone S, Nassi L, Farina C, Viscoli C, Rossolini GM, Bonifazi F, and Rambaldi A, 'Incidence, Risk Factors and Outcome of Pre-Engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65 (2017), 1884-96.
14 Chinese Society of Hematology Chinese Medical Association Red Blood Cell Disease Group, '[Chinese Expert Consensus on the Diagnosis and Treatment of Aplastic Anemia (2017)]', Zhonghua Xue Ye Xue Za Zhi, 38 (2017), 1-5.
15 Criscuolo M, and Trecarichi EM, 'Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences', Antibiotics (Basel, Switzerland), 9 (2020).
16 Jorgensen SCJ, Trinh TD, Zasowski EJ, Lagnf AM, Bhatia S, Melvin SM, Steed ME, Simon SP, Estrada SJ, Morrisette T, Claeys KC, Rosenberg JR, Davis SL, and Rybak MJ, 'Real-World Experience with Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections', Open forum infectious diseases, 6 (2019), ofz522.
17 Zhu XF, He HL, Wang SQ, Tang JY, Han B, Zhang DH, Wu LQ, Wu DP, Li W, Xia LH, Zhu HL, Liu F, Shi HX, Zhang X, Zhou F, Hu JD, Fang JP, Chen XQ, Ye TZ, Liang YM, Jin J, and Zhang FK, 'Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study', Acta haematologica, 142 (2019), 162-70.
18 Guimarães T, Nouér SA, Martins RCR, Perdigão Neto LV, Martins WMBS, Narciso Barbosa AC, Ferreira ALP, Costa SF, and Gales AC, 'Enterobacterialesceftazidime-Avibactam as Salvage Therapy for Infections Caused by Coresistant to Carbapenems and Polymyxins', Antimicrobial agents and chemotherapy, 63 (2019).
19 Karlowsky JA, Kazmierczak KM, Bouchillon SK, de Jonge BLM, Stone GG, and Sahm DF, 'In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa Collected in Asia-Pacific Countries: Results from the Inform Global Surveillance Program, 2012 to 2015', Antimicrobial agents and chemotherapy, 62 (2018).
20 M. P. Ledoux, B. Guffroy, Y. Nivoix, C. Simand, and R. Herbrecht, 'Invasive Pulmonary Aspergillosis', Semin Respir Crit Care Med, 41 (2020), 80-98.